Alpha 2.0
Login Register
» Authors » P Kalhs

P Kalhs

Explore the profile of P Kalhs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 583
Followers 0
Related Specialties
Hematology
General Surgery
Oncology
Top 10 Co-Authors
H T Greinix
K Lechner
F Keil
W Rabitsch
E Reiter
I Schwarzinger
A Schulenburg
C Mannhalter
N Worel
P Hocker
Published In
Bone Marrow Transplant
Ann Hematol
Leukemia
Blood
Transplantation
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
Martino R, Henseler A, van Lint M, Schaap N, Finke J, Beelen D, et al.
Bone Marrow Transplant . 2017 Mar; 52(8):1107-1112. PMID: 28319072
This study shows the long-term updated outcomes of a multicenter retrospective study which analyzed 843 patients with myelodysplastic syndrome (MDS) who underwent transplantation with an HLA-identical sibling donor with either...
2.
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Rabitsch W, Bojic M, Wohlfarth P, Leiner M, Schorgenhofer C, Kalhs P, et al.
J Cancer Res Clin Oncol . 2016 Feb; 142(6):1307-14. PMID: 26920356
Purpose: Treatment of refractory Hodgkin disease deserves specific considerations. Recently, alemtuzumab-BEAM has been introduced in allogeneic hematopoietic stem cell transplantation (HSCT) in these patients. Methods: We retrospectively analyzed the outcome...
3.
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study
Kuzmina Z, Eder S, Bohm A, Pernicka E, Vormittag L, Kalhs P, et al.
Leukemia . 2011 Sep; 26(4):746-56. PMID: 21926960
Chronic graft-versus-host disease (GVHD) remains a serious complication after allogeneic hematopoietic stem cell transplantation (HCT). In 2005 the National Institutes of Health (NIH) established new criteria for chronic GVHD based...
4.
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country
Rosenmayr A, Pointner-Prager M, Mitterschiffthaler A, Bozic L, Pelzmann B, Tuchler H, et al.
Bone Marrow Transplant . 2011 Apr; 47(2):172-80. PMID: 21460872
Between 1988 and 2007, international searches for matched unrelated donors (MUDs) were performed for 1586 Austrian patients. Between 2004 and 2007, a MUD was identified for 76.7% of the patients....
5.
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation
Ludajic K, Balavarca Y, Bickeboller H, Rosenmayr A, Fae I, Fischer G, et al.
Bone Marrow Transplant . 2009 Jan; 44(2):97-103. PMID: 19169284
Interactions of polymorphic killer Ig-like receptor (KIR) receptors with KIR ligands have been shown to modify the outcome of hematopoietic SCT (HSCT). The association of these genetic factors with different...
6.
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation
Boehm A, Sperr W, Leitner G, Worel N, Oehler L, Jaeger E, et al.
Eur J Clin Invest . 2008 Nov; 38(12):945-52. PMID: 19021720
Background: Recent data suggest that, among other factors, comorbidity may be an important prognostic variable in patients with myelodysplastic syndromes (MDS) who are eligible for haematopoietic stem cell transplantation (SCT)....
7.
Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study
Leitner G, Baumgartner K, Kalhs P, Biener D, Greinix H, Hoecker P, et al.
Bone Marrow Transplant . 2008 Oct; 43(5):357-63. PMID: 18936736
Mobilized allogeneic PBPC are increasingly used instead of BM for allogeneic stem cell grafting. Although the short-term safety profile of recombinant human (rh)G-CSF seems acceptable, only minimal data on long-term...
8.
Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature
Mueller-Mang C, Mang T, Kalhs P, Thurnher M
Neuroradiology . 2005 Nov; 48(2):84-9. PMID: 16283282
Toxoplasmosis encephalitis is a severe, but often misdiagnosed complication in patients after bone marrow transplantation (BMT). We describe the unique computed tomography (CT) and magnetic resonance (MR) imaging features of...
9.
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors
Greinix H, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B, et al.
Bone Marrow Transplant . 2004 Nov; 35(1):57-62. PMID: 15531903
There is consensus that matching of unrelated donors (URD) and patients for HLA class II alleles improves the outcome of hematopoietic stem cell transplantation (HSCT). However, the significance of HLA...
10.
Bone metabolism in patients more than five years after bone marrow transplantation
Kerschan-Schindl K, Mitterbauer M, Fureder W, Kudlacek S, Grampp S, Bieglmayer C, et al.
Bone Marrow Transplant . 2004 Aug; 34(6):491-6. PMID: 15286695
We investigated the bone metabolism of 22 patients (median age 38 years) over 6 years after allogeneic bone marrow transplantation (BMT). Biplanar roentgenograms of the thoracic and lumbar spine were...